<DOC>
	<DOCNO>NCT02916641</DOCNO>
	<brief_summary>Ursodeoxycholic acid ( UDCA ) treatment PBC approve US European drug administration . Long-term use UDCA ( 13â€”15 mg/kg/day ) patient PBC improve serum liver biochemistry survival free liver transplantation However , 40 % patient respond UDCA optimally assess know criterion biochemical response . Those patient represent group need additional therapy , increase risk disease progression decrease survival free liver transplantation . And UDCA less effect PBC patient whose pathology stage 3-4 . Liver fibrosis might jeopardize UDCA effect . Fuzhenghuayu Chinese traditional medicine liver fibrosis cirrhosis . Both lab research clinical study suggest Fuzhenghuayu could significantly reverse liver fibrosis cirrhosis due different kind etiology . Here start random , open parallel clinical research explore effect Fuzhenghuayu combine UDCA PBC treatment .</brief_summary>
	<brief_title>Fuzhenghuayu Patients With PBC Who Had An Inadequate Response Ursodeoxycholic Acid</brief_title>
	<detailed_description />
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>1 . Signed informed consent 2 . Patient PBC define 2 3 follow criterion : a.Positive antimitochondrial antibody type M2 ; b.Abnormal serum alkaline phosphatase ( ALP &gt; 1,5N ) aminotransferase ( AST ALT &gt; 1N ) activity ; c.Histological hepatic injury consistent PBC . 3 . Had treat UDCA 6 month , fail achieve complete biochemical response . 1 . Pregnancy desire pregnancy . 2 . Breastfeeding . 3 . Coexisting liver disease acute chronic viral hepatitis , alcoholic liver disease , choledocholithiasis , autoimmune hepatitis , biopsyproven nonalcoholic fatty liver disease , Wilson 's disease hemochromatosis . 4 . History presence hepatic decompensation ( e.g. , variceal bleeds , encephalopathy , poorly control ascites ) . 5 . History urolithiasis , nephritis renal failure ( clearance creatinine &lt; 60 ml/mn ) . 6 . Hepatotoxic drug use recruiting . 7 . Fuzhenghuayu anaphylaxis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fuzhenghuayu</keyword>
</DOC>